Lyra Therapeutics Inc
NASDAQ:LYRA
Lyra Therapeutics Inc
NASDAQ:LYRA
Price:
0.4902
USD
22.24%
Market Closed
Market Cap:
$867.7k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lyra Therapeutics Inc
NASDAQ:LYRA
|
US |
|
M
|
MicroCloud Hologram Inc
NASDAQ:HOLO
|
US |
|
Coca-Cola Icecek AS
IST:CCOLA.E
|
TR |
|
E
|
Eastcompeace Technology Co Ltd
SZSE:002017
|
CN |
|
John Wiley & Sons Inc
NYSE:WLYB
|
US |
|
A
|
AJ Plast PCL
SET:AJ
|
TH |
|
G
|
Great Water Holdings Ltd
HKEX:8196
|
CN |
|
T
|
Tenderhut SA
WSE:THG
|
PL |
|
Omega Healthcare Investors Inc
NYSE:OHI
|
US |
|
Orion Energy Systems Inc
NASDAQ:OESX
|
US |
|
Objective Corporation Ltd
ASX:OCL
|
AU |
|
E.ON SE
LSE:0MPP
|
DE |
|
Cascades Inc
TSX:CAS
|
CA |
|
M
|
Magellan Health Inc
F:MAH1
|
US |
|
W
|
Weigang Environmental Technology Holding Group Ltd
HKEX:1845
|
CN |
Relative Value
The Relative Value of one
LYRA
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 0.4902 USD,
Lyra Therapeutics Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LYRA Relative Value
HIDDEN
Multiples Across Competitors
LYRA Competitors Multiples
Lyra Therapeutics Inc Competitors
Lyra Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Lyra Therapeutics Inc
NASDAQ:LYRA
|
806.1k USD | 1.3 | -0 | 0.7 | 0.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD | 13.1 | 41.3 | 27.9 | 29.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.5B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.4B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.2B GBP | 4.9 | 28.3 | 15.7 | 22.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288B USD | 4.4 | 15.8 | 9.8 | 11.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.4B CHF | 5.2 | 21.1 | 13 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.3B USD | 2.4 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.5B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
